1. Introduction {#sec0001}
===============

As a result of the coronavirus (COVID-19) pandemic, governments around the world have instituted physical distancing measures to contain transmission and limit the potential for healthcare system saturation that could result in unnecessary deaths. From a population health perspective, physical distancing is critically important, although the direct and indirect impact (i.e. through economic downturn) it may have on mental health is of significant concern ([@bib0040]). COVID-19 containment measures, including the physical-isolation strategies implemented by the Australian Government in late March 2020 ([@bib0043]), may be especially aversive for individuals with pre-existing mood disorders. This is because they disrupt a myriad of factors critical to the management of clinical and cognitive symptoms, including easy access to in-person psychiatric care, and stability in daily routines, social rhythms and sleep patterns ([@bib0002]; [@bib0005]; [@bib0014]; [@bib0041]). In those with a mood disorder, the occurrence of such disruptions in the context of economic volatility and financial insecurity, is likely to perpetuate the natural negative emotional responses (i.e. depression, anxiety and stress) that occur in the face of disaster ([@bib0029]; [@bib0039]).

Further, in mood disorders there is a heightened prevalence of co-occurring medical conditions such as obesity, diabetes and cardiovascular disease ([@bib0006]; [@bib0009]; [@bib0012]; [@bib0023]). These have been linked to a more severe coronavirus 2 (SARS-CoV-2) manifestation ([@bib0046]), and may amplify psychological distress by increasing a patient\'s worries about the heightened personal risk of infection-related mortality or poor long-term health outcomes ([@bib0011]; [@bib0022]; [@bib0046]). Compounding this, may be worries about adverse psychiatric and COVID-19 drug treatment interactions should one become infected, or by the potentially negative implications for oneself should one\'s carer(s) become infected ([@bib0037]).

Disaster research indicates that up to 40% of distressed individuals presenting for mental health assistance during or post disaster have pre-existing psychiatric disorders ([@bib0029]). To date, several studies have characterised the mental health status of the general population in relation to COVID-19 in different countries, but work comparing community-living individuals with a pre-existing mood disorder to those with no mental disorder is lacking. To elucidate the current mental health needs of those with a mood disorder, observational studies that identify specific COVID-19 related concerns and characterise related lifestyle changes and psychological distress in this population are needed. This will inform evidence-based strategies for patient care in the clinic, and help to mitigate long-term symptom exacerbation and adverse psychological outcomes in these individuals.

In this paper, we address this need by reporting outcomes from the COvid-19 and you: mentaL heaLth in AusTralia now survEy (COLLATE), a nationwide study aimed at understanding the impact of the COVID-19 pandemic on the mental health and wellbeing of Australians. Using cross-sectional data from wave 1 of the project, we compared respondents self-reporting a pre-existing mood disorder and those with no reported mental disorder in terms of their; i) primary concerns related to COVID-19, ii) COVID-19 related changes in personal situation, perceptions or behaviours, and iii) current psychological distress levels. In secondary analyses we compared individuals with depressive disorder and bipolar disorder on these factors. We hypothesised that psychological distress levels would be elevated in the mood disorder groups, and that distress levels would be associated with an increased presence of negative behavioural change in areas relevant to maintaining stable mood, including sleep, exercise and alcohol use.

2. Method {#sec0002}
=========

This study received ethics approval from the Swinburne University Human Research Ethics Committee (approval number: 20202917-4107) and complied with the Declaration of Helsinki.

2.1. Design {#sec0003}
-----------

The COLLATE project is a population-based study that includes a series of anonymous online surveys, open for 72 hours at the beginning of each month for 12 months. This is followed by annual surveys until 2024, which will allow for future longitudinal data collection and characterisation ([@bib0031]; [@bib0040]). The *cross-sectional* findings from wave 1 of the COLLATE project are reported here. Members of the general public residing in Australia, aged 18 years or older were invited to complete the survey over a time period extending from April 1'st to April 4'th 2020. This coincided with federal and state mandated restrictions (Stage 3) coming into effect, whereby Australians were expected to self-isolate as much as reasonably possible ([@bib0007]; [@bib0043]). This self-isolation meant Australians were only allowed to leave their homes for essential activities, such as employment, exercise, medical care, or to buy groceries.

Respondents were recruited through social media and other advertisements, participant registries and non-discriminative snowball sampling. Respondents completed the survey which covered three broad topics: a) current concerns, b) current emotional experiences, and c) socio-demographics/risk factors. Within this, they were asked to respond to one question asking them to self-identify whether they had a mental illness, and if so, which mental illness/es they had. Measures relevant to the aims of this paper are described below.

2.2. Measures {#sec0004}
-------------

*[Primary concerns related to COVID-19]{.ul}:* Respondents were asked to identify and rank their top 10 concerns relating to the COVID-19 pandemic from 23 options (see [Table 1](#tbl0001){ref-type="table"} ).Table 1Items relating to current concerns about the COVID-19 pandemic ranked by frequency of endorsement for each groupTable 1ItemsNo mental disorderMood disorderDepressive disorderBipolar disorderImplications for health and wellbeing of family/loved ones**1112**Loved one dying from COVID-19**2223**Loved one catching COVID-19**3334**Implications for health and wellbeing of society**4445**Australian economy**51010**13Catching COVID-19 myself**688**11Implications for health and wellbeing of self**7551**Social isolation and social distancing**8668**Availability of food and medicines**9776**Dying of COVID-19 myself**10**121212Access to appropriate medical care11**999**World economy12141415Personal finances131111**10**Risk of unemployment or reduced employment141313**7**Travel restrictions15171716The rapidly changing landscape16151514Balancing work & caring for children/dependents17212118Government communication of key messages18161620Media coverage of the pandemic19181817Adapting to working from home (e.g. IT/connectivity issues)20202019Domestic violence21191921Others22222222Not being able to attend regular place of worship23232323[^2]

*[COVID-19 related changes in personal situation, perceptions or behaviours]{.ul}* were measured through self-reported changes (in the previous week) in employment status, work arrangements and perceived difficulty working from home, as well as non-employment related contact with others outside the home. Lifestyle factors including exercise, sleep and drinking compared to the period before the COVID-19 pandemic began were also measured, as well as ratings of the perceived impact of government restrictions on mental health and expectations about time to return to 'normal' (see Supplementary Table 1 for details).

*[Psychological distress]{.ul}* was measured with the 21-item *Depression Anxiety Stress Scale* (*DASS-21*; [@bib0021]). The DASS-21 yields three subscales, each comprising seven items scored on a four-point scale from never (0) to almost always (3). Higher subscale scores reflect higher levels of depression, anxiety, and stress in the past week, with a higher sum score representing greater general distress. DASS-21 raw scores were doubled for comparability to full-length (42 items) DASS scores.

*[Confounding variables]{.ul}* of interest included age, gender and momentary affect, as measured by the *Positive and Negative Affect Schedule* (*PANAS*; [@bib0044]). The PANAS is a 20-item measure comprising a 10-item scale measuring indicators of positive affect (PA) and a 10-item scale measuring indicators of negative affect (NA). It is scored on the extent to which one has a particular feeling at that moment, with ratings on a 5-point scale ranging from very slightly or not at all (1) to extremely (5). A high score on the Positive Affect scale reflects an energetic and alert mood state, whereas a high score on the Negative Affect scale indicates greater levels of general distress. Items include "distressed" (NA scale) and "excited" (PA scale).

2.3. Statistical analyses {#sec0005}
-------------------------

Respondents who self-identified as having a mood disorder (either a bipolar or depressive disorder)[2](#cit_1){ref-type="fn"} were compared to individuals that did not self-identify as having a mental disorder using the Statistical Package for the Social Sciences (SPSS) v24.0.

First (1), chi-square or one-way analysis of variance was used to ascertain the presence of group differences in age, gender and momentary affect. Pearson or Spearman correlations were then conducted to examine associations between these variables and psychological distress. Second (2), the frequency of endorsements for each of the 23 items of concern was obtained for each group. For each respondent, rankings of zero were assigned to options not endorsed, and then mean rankings (scale 1-10) per group were computed for the 10 most commonly selected options for each group. Third (3), chi-square and column proportions tests were used to compare categorical responses within the nominal variables assessing COVID-19 related changes in personal situation, perceptions or behaviours across groups. Fourth (4), DASS total and subscale scores were square root (SQRT) transformed to account for positive skew in the sample, and then entered as dependent variables in a multivariate analysis of covariance. Given significant, albeit mild, correlations (*r\'s =*.1-.2, *p\'s*\<.001) between confounding variables ascertained at the first step, group was entered as a fixed factor alongside gender, while age and both PANAS subscale scores were entered as covariates. The estimated marginal means of the square root transformed DASS scores were back-transformed to determine their place among the four defined DASS severity levels (normal, mild, moderate, severe/extremely severe) and to compare the scores of respondents with no mental disorder to norms from a non-clinical Australian sample[3](#cit_2){ref-type="fn"} . Finally (5), to assess whether DASS total scores differed by the levels of the variables assessing COVID-19 related changes in personal situation, perceptions or behaviours, univariate analyses of covariance were conducted, with each given nominal variable and group entered as fixed factors and DASS score as the dependent variable.

Analyses 1-4 were first conducted to compare respondents with a self-reported mood disorder and those not reporting any mental disorder, and then comparing those with depressive disorder to those with bipolar disorder. The univariate analyses (step 5) were not analysed by mood disorder subtype given likely inadequacies in power from stratification analyses of the (relatively) modest number of respondents self-reporting bipolar disorder. A conservative alpha of *p*\<.01 was adopted for all first-level analyses, while post-hoc test results were corrected using Tukey\'s method where necessary.

3. Results {#sec0006}
==========

A total of 8,014 respondents participated in survey 1 of the COLLATE project. There was substantial missing data for n=2545 respondents, and n=1010 of the remaining 5,469 respondents reported a mental disorder other than bipolar or depressive disorder. The final sample included the data of the n=1292 respondents self-reporting a mood disorder (either bipolar disorder or depressive disorder) and the n=3167 without any reported mental disorder.

3.1. Primary concerns {#sec0007}
---------------------

[Table 1](#tbl0001){ref-type="table"} shows the items relating to current concerns about the COVID-19 pandemic ranked by the frequency of endorsement in each group. [Figure 1](#fig0001){ref-type="fig"} shows the mean rankings of the top 10 most frequently endorsed items for each group ordered by mean ranking from most concerning (1) to least concerning (10). The most frequently endorsed item for those with a mood disorder *and* those with no mental disorder was "Implications for health and wellbeing of family/loved ones". Compared to those with no mental disorder, "Dying of COVID-19 myself" did not fall into the top 10 most frequently endorsed items for respondents with a mood disorder. Instead, "Access to appropriate medical care" was included and ranked 9'th in order of importance.Fig. 1Top 10 most frequently endorsed concerns for each group ordered by mean ranking from most concerning (1/left) to least concerning (10/right).Note: Values reflect item ordering in the leftmost column in [Table 1](#tbl0001){ref-type="table"}; 1=Implications for health and wellbeing of family/loved ones; 2= Loved one dying from COVID-19; 3=Loved one catching COVID-19; 4= Implications for health and wellbeing of society; 5=Australian economy; 6= Catching COVID-19 myself; 7= Implications for health and wellbeing of self; 8=Social isolation and social distancing; 9=Availability of food and medicines; 10=Dying of COVID-19 myself; 11=Access to appropriate medical care; 12=World economy; 13=Personal finances; 14=Risk of unemployment or reduced employment. Blue bars indicate deviation from top 10 most endorsed items by the group with no mental disorder. Error bars represent standard deviation.Fig. 1

When respondents with a mood disorder were separated by type, "Access to appropriate medical care", "Risk of unemployment or reduced employment" and "Personal finances" were ranked in the top 10 most endorsed concerns for those with bipolar disorder (ranked 3'rd, 8'th and 10'th by importance). This was in place of "Australian economy" and "Catching COVID -19 myself" for respondents with depressive disorder (ranked 8'th and 4'th by importance); and "Catching COVID 19 myself", "Dying of COVID -19 myself" and "Australian economy" in respondents with no mental disorder (ranked 5'th, 4'th and 9'th by importance).

3.2. COVID-19 related changes in personal situation, perceptions or behaviours {#sec0008}
------------------------------------------------------------------------------

Within the mood disorder group, there were no differences in the personal situation, perceptions or behaviours of respondents with depressive disorder versus bipolar disorder (see Supplementary Table 4). [Table 2](#tbl0002){ref-type="table"} reports the proportions for these factors comparing the group with no mental disorder to the group with a mood disorder irrespective of subtype*.* Although the pattern of *within-group* proportion differences on all variables did not differ between those with a mood disorder and those without a mental disorder (see Supplementary Tables 2 and 3), there were significant differences in the distribution of responses *between* groups for several variables.Table 2Age and PANAS descriptives, and comparisons of the proportions of respondents with no mental disorder versus respondents with mood disorder endorsing each category of the variables assessing COVID-19 related changes in personal situation, perceptions or behaviours.Table 2NO MENTAL DISORDERMOOD DISORDERCOMPARISONS***n* per analysisProportion (%)M(SD)*n* per analysisProportion (%)M(SD)Test statisticdfP valueEffect size**Age\*316742.26(14.11)129237.16 (11.84)151.601,2832.55**\<.001**0.39Positive affect\*305325.7(8.33)126122.44(7.61)154.731,2556.40**\<.001**0.41Negative affect\*305317.86(6.98)126121.45 (7.86)198.091,2120.2**\<.001**0.48GenderMale\
Female316720.7^a^\
79.3^a^129213.5\
86.531.101**\<.001**0.08Job lossYes\
No, reduced hours\
No but expected\
No31559.3^a^\
12.4\
7.1\
71.2^a^129013.6\
13.4\
7.3\
65.723.363**\<.001**0.07Work from homeYes\
No316541.2^a^\
58.8^a^129146.6\
53.411.181**.001**0.05Work from home difficultyVery difficult\
Somewhat difficult\
No issues185710.2^a^\
51.1\
38.7^a^68819.6\
51.6\
28.848.462**\<.001**0.14Change in non-employment related contact with others outside the homeNo change\
Less time\
More time316436.1\
44.0^a^\
19.9^a^129233.6\
49.3\
17.111.242**.001**0.05Change in exercise behaviourMore\
Less\
No change or I do not exercise normally^+^316636.0^a^\
42.3\
21.7129132.1\
45.1\
22.8\
5.972.050.04Change in sleep durationMore\
Less\
No change^+^316526.4^a^\
42.3^a^\
31.3^a^129135.6\
46.7\
17.793.382**\<.001**0.15Change in drinking behaviourMore\
Less\
No change^+^312228.8^a^\
13.8\
70.7^a^126735.4\
12.1\
52.518.682**\<.001**0.07Perceived impact of government restrictions on mental healthPositive\
Negative\
No impact^+^316225.4^a^\
54.8^a^\
19.9^a^129218.4\
70.0\
11.591.462**\<.001**0.14Expectations about return to 'normal'\<3 months\
\<6 months\
\<12 months\
\>12 months\
No idea31584.7^a^\
29.1^a^\
38.2^a^\
17.6\
10.412863.0\
23.6\
41.8\
19.5\
12.124.144**.001**0.07[^3]

A higher proportion of the group with a mood disorder had lost their jobs as a result of COVID-19 compared to the group with no mental disorder, but the groups did not differ in the proportion of respondents working reduced hours or expecting to lose their job. A higher proportion of the mood disorder group were working from home compared to the group with no mental disorder; with double the proportion finding it 'very difficult' due to motivational or technical reasons, and 10% less having 'no issues'. Compared to the group with no mental disorder, a higher proportion of respondents with mood disorder had less non-employment related contact with others outside the home compared to before the pandemic. Further, more experienced sleep disruptions, with less reporting no change and more reporting sleeping both more *and* less since the pandemic began. More mood disorder respondents also reported drinking more since the pandemic began, while less reported no change compared to the group with no mental disorder.

A perceived positive impact or no change in mental health as a result of government restrictions was reported by fewer respondents in the mood disorder compared to the group with no mental disorder, while 15% more respondents in the mood disorder group reported a negative impact. Finally, more respondents in the mood disorder group expected it to take longer for life to return to 'normal' than the group with no mental disorder i.e., less than 12 months versus less than six.

3.3. Psychological distress {#sec0009}
---------------------------

Group differences in DASS scores are shown in [Fig. 2](#fig0002){ref-type="fig"} (see Supplementary Table 5 for statistical values and Supplementary Table 6 for severity levels and comparison to non-clinical norms). As expected, psychological distress was elevated in respondents self-reporting a mood disorder compared to those with no mental disorder for all subscales of the DASS and the total score, after adjusting for momentary affect, age and gender. Mean scores remained in the 'normal' range across subscales for the group with no mental disorder, albeit with a 25-30% increase relative to *published norms* for depression and stress. In the mood disorder group, mean scores indicated moderate levels of depression, normal levels of anxiety and mild stress. Large effects were evident between those with no mental disorder and those with a mood disorder. Respondents with depressive disorder had lower stress levels (mild) than those with bipolar disorder (moderate), but anxiety was mild and equivalent in both subgroups. A significant group by gender interaction was evident for depression and total scores, where males and females with depressive disorder did not differ, but males with bipolar disorder had higher scores (borderline of severe and extremely severe) than females (moderate) with bipolar disorder.Fig. 2*Square root (SQRT) transformed Depression, Anxiety and Stress Scales (DASS) scores by group.* Numbers in figures represent Cohen\'s d effects. Errors bars represent standard error.a) DASS scores for respondents with no mental disorder versus a mood disorder. No group\*gender interactions evident. Bars represent estimated marginal means adjusting for age, gender and momentary affect. Blue lines represent main effects of group.b) DASS scores for respondents with depressive disorder versus bipolar disorder. Group\*gender interactions were not evident for these variables. Bars represent estimated marginal means adjusting for age, gender and momentary affect. Blue lines represent main effects of group.c) Gender\*group interactions for depressive disorder versus bipolar disorder. Bars represent estimated marginal means adjusting for age and momentary affect. Blue lines represent gender differences in the bipolar disorder group (p≤.05 corrected \[Tukey\]). Cohens d= 0.02 vs. 0.08 for males vs females with depressive disorder and d=0.44 vs 0.36 for males and females with bipolar disorder.Fig. 2

[Fig. 3](#fig0003){ref-type="fig"} shows the differences in DASS total scores for each level of the variables assessing COVID-19 related changes in personal situation, behaviours and perceptions between respondents with a mood disorder and those with no mental disorder. Significant main effects were evident for every variable (see also Supplementary Table 7), as were main effects of group; with mood disorder respondents having higher scores than those with no mental disorder irrespective of response to each variable.Fig. 3Square root (SQRT) transformed Depression Anxiety and Stress Scale (DASS) scores as a function of COVID-19 related changes in personal situation, perceptions or behaviours in respondents with no mental disorder versus those with self-reported mood disorder.Note bars represent estimated marginal means. A conservative alpha of p≤.01 was adopted at the first level. Post-hoc results are significant at p≤.05 corrected (Tukey). All comparisons are significant, except those represented by orange (main effect of group) or blue (interaction: mood disorder only) lines. Errors bars represent standard error.Fig. 3

Interaction effects were also evident for three variables, where in the mood disorder group, higher DASS scores were evident in respondents working from home than those who were not, but did not differ between those reporting 'more' *or* 'no change' in social time with others, or those reporting a 'positive' *or* 'no impact' of government restrictions on mental health. By contrast, DASS scores in the group with no mental disorder were higher for the former than the latter but did not differ by work location. In both groups, respondents who were spending less time with others outside the home or were perceiving a negative impact of government restrictions on mental health had higher DASS scores compared to those endorsing other categories, although scores were higher for those with a mood disorder.

4. Discussion {#sec0010}
=============

In this paper we provide an overview of the key current concerns, situational, perceptual and behavioural changes, and psychological distress levels of Australian\'s self-reporting a pre-existing mood disorder compared to those with no mental disorder during the COVID-19 pandemic. As expected, depression, anxiety, stress and general distress was heightened in the former compared to the latter, with all but anxiety further elevated in respondents with bipolar disorder compared to those with depressive disorder (albeit with small effects); and men with bipolar disorder having even higher levels of depression and general distress than women with bipolar disorder. This latter finding contradicts that of several prior studies showing the opposite gender effect under non-pandemic conditions ([@bib0001]; [@bib0027]; [@bib0030]), such that males with bipolar disorder appear to be experiencing particularly severe psychological ill-health during the time of COVID-19. In light of evidence that suicidality is more common in males and the severely depressed ([@bib0013]; [@bib0019]), this subgroup of people may be at an especially high risk of suicide given that their mean current depression severity fell at the borderline of severe and extremely severe.

The top 10 most frequently endorsed concerns related to COVID-19 appeared to be generally similar for individuals with mood disorders and those with no mental disorder; with the top 4 reflecting concerns for the health and wellbeing of loved ones, including loved ones catching or dying from COVID-19, and the health and well-being of society. However, compared to those with no mental disorder, respondents with a mood disorder were more likely to express concern for access to appropriate medical care, and were less likely to be concerned about dying of COVID-19 themselves. Within this, respondents with bipolar disorder were more likely to be concerned about their personal finances and their risk of unemployment or reduced employment than those with depressive disorder, and less likely than them to be concerned with the Australian economy or catching COVID-19 themselves.

While all groups were *most* concerned about the prospect of a loved one dying of COVID-19 followed by them contracting it, those with no mental disorder or a depressive disorder were next most concerned about implications for the health and well-being of loved ones, while those with bipolar disorder were next most concerned about the risk of unemployment or reduced employment. Notably however, although more respondents with a mood disorder had lost their job as a result of COVID-19 compared to respondents with no mental disorder, job loss rates or expectations about job loss did not differ between respondents with bipolar disorder and those with depressive disorder. The more common endorsement of items relating to financial stress in the former may thus be reflective of the heightened economic burden of bipolar disorder compared to the latter.

Indeed, there is evidence that healthcare utilisation costs are higher for bipolar disorder than depressive disorder, particularly for specialised psychiatric (as opposed to primary care) and pharmaceutical services ([@bib0045]). In terms of work productivity, the cost per year to bipolar disorder is double that of depressive disorder, with a greater number of lost work days, and thus income, likely to confer heightened financial disadvantage ([@bib0015]). Reduced financial life-satisfaction has been documented in bipolar disorder previously ([@bib0042]), where impulsive risk-taking behaviours such as reckless spending are central to (hypo)mania and represent a major source of financial difficulty and subsequent stress ([@bib0034]). The convergence of these factors may thus confer a heavier personal financial strain to those with bipolar disorder, for which concern may be currently amplified by the economic precarity of the COVID-19 situation.

As expected, changes to lifestyle behaviours that are known to be important for emotional stability were more prevalent in individuals with a mood disorder; but did not differ between those with depressive disorder or bipolar disorder. That is, compared to those with no mental disorder, a higher proportion of individuals with a mood disorder reported spending less time in non-employment related contact with others, getting more or less sleep, and drinking more since the pandemic began. Further, a higher proportion expected it to take longer for life to return to 'normal', or perceived a negative impact of government restrictions on mental health. Psychological distress was highest in individuals reporting adverse situational or behavioural changes/perceptions; with those sleeping or exercising less more distressed than those sleeping or exercising more, and those who had lost their jobs more distressed than those who had not or those working reduced hours, but not those still expecting to. These same patterns were also evident in the individuals with no mental disorder, although general distress was higher in the mood disorder group compared to the no mental disorder group in every case.

Notably, respondents with a mood disorder were also more likely to find it very difficult to work from home due to technical or motivational reasons than those with no mental disorder. Those with a mood disorder were also more distressed if they were working from home than if they were not, particularly if they found it very difficult to do so. It is possible that this distress could be mitigated, in part, through regular employer check-ins or the provision of extra assistance to vulnerable staff who may be known to experience extremes of mood.

From the perspective of mood stability, the high proportion of individuals reporting COVID-19 related changes in situational and lifestyle factors key to its maintenance is concerning. It thus seems evident that the focus of population-based health promotion should be on ways to maintain a healthy lifestyle in the home even in the context of physical distancing restrictions. From a clinical care standpoint, individuals with mood disorders who report acute changes in maladaptive lifestyle behaviours should be monitored even more closely, especially given the association of these behaviours with elevated levels of depression, anxiety, and stress reported here. Psychoeducation in the form of healthy lifestyle-based guidance seems particularly pertinent for these individuals, given that that the impact of maladaptive lifestyle changes may unfortunately extend beyond emotional symptom exacerbation.

Indeed, lifestyle behaviours are key mediators of physical and cognitive health, which is typically compromised in bipolar and depressive disorder already ([@bib0010]; [@bib0026]). There is evidence that cessation of exercise, as well as sleep loss and increased alcohol intake, can amplify cardiometabolic dysfunction by altering biochemical and inflammatory marker profiles, reducing insulin sensitivity and inducing hypertriglyceridemia ([@bib0004]; [@bib0020]; [@bib0032]). These factors have been widely linked to cognitive impairment as well as metabolic disease, to which those with mood disorders are more susceptible by virtue of genetic diathesis or psychotropic medication use ([@bib0016]; [@bib0017]; [@bib0024]; [@bib0025]; [@bib0028]; [@bib0033]; [@bib0038]). Thus, the maladaptive lifestyle changes documented in this group in response to COVID-19 might not only contribute to emotional decline and also cognitive impairment, but may further compound the risk of severe SARS-CoV-2 infection and associated medical complications ([@bib0046]).

There are several factors that should be considered in the interpretation of our findings. First, we have described data from the first wave of the mental-health-focused COLLATE project dataset, in which participation was self-selected and subsequent sample representativeness potentially biased. Second, the data we report is cross-sectional, and any changes in situation, perceptions and behaviours since the pandemic began were retrospectively reported using non-validated questions devised by the authors. Longitudinal data is being collected to address this as part of the ongoing COLLATE project. Third, as the COLLATE project is population-focused, the presence (or absence) of mood disorder was self-reported. Medication use and other important clinical variables such as age of onset, psychosis history, bipolar subtype or predominant polarity was also not measured, nor were symptoms of relevance to mania. Hence, diagnosis of (or absence of) mental disorder could not be clinically verified and the clinical characteristics of the mood disorder group not ascertained. Nonetheless, there is evidence that individuals self-identifying as having bipolar disorder or depressive disorder typically meet criteria for each respective diagnosis ([@bib0018]; [@bib0036]). Fourth, the number of individuals self-reporting a mood disorder in the sample was modest and the gender distribution within this unbalanced. Thus, caution should be used in interpreting the results of analyses of this subsample stratified by gender.

Finally, given the unexpected nature and fast-paced way in which the COVID-19 pandemic took hold, we do not have pre-COVID-19 baseline measures of mood and lifestyle in our respondents. Thus, we cannot be sure that the high levels of psychological distress in those with mood disorder reported here are a result of the pandemic. It is certainly a reasonable assumption that heightened distress in this group reflects pre-existing symptomatology inherent to the very essence of mood disorder. However, since variations in distress were associated with self-reported changes in personal situation, perceptions and lifestyle behaviours directly tied to COVID-19 in largely the same manner as seen in those without a mental disorder, it is plausible that such symptoms have *worsened on account of the social and economic consequences of the virus*.

In sum, the data reported here indicates that current psychological distress levels are elevated in individuals with mood disorder and are associated with maladaptive situational and lifestyle changes occurring in response to COVID-19. Concerns related to the pandemic strongly centre around the health and wellbeing of loved ones, oneself and society, as well as access to food, medicines and appropriate medical care. Individuals with bipolar disorder also appear to be more uniquely concerned about personal finances and unemployment than they are about the broader economy. In light of evidence that financial worries may represent a 'final straw' that triggers self-harm and suicidality ([@bib0003]; [@bib0035]), especially close attention to the mental health of individuals with bipolar disorder may be warranted. This is pertinent given the very severe levels of depression currently evident in males with the disorder, and the widespread economic hardships that are likely to be encountered as the pandemic continues to unfold.
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